Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,868.77
(
0.16%
)
News Focus
News Focus
Post# of 518960
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4021
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: baltimorebullet post# 444664

Friday, 12/29/2023 10:25:15 AM

Friday, December 29, 2023 10:25:15 AM

Post# of 518960
Pre-commercial biopharm is a ride. IMO lots of slack should be cut to all of them. SAVA has a 25 year track record of simply not delivering - it talked up its opioid for over a dozen years and then that failed. Will simufilam be different? Maybe. Hope so. But the same kind of management pumping is in force as before.- at least a yellow light. And the OL data and the short blinded extension data was...no bueno.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News